MedTrace Logo

Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Depression

NCT01516931 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 391

Last updated 2020-01-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of the symptoms of depression. Primary Outcome Measures:Time between subject randomization to treatment and the first occurrence of a relapse during the Relapse Prevention Period. Secondary Outcome Measures: Symptom change as measured by Hamilton Depression Rating Scale (HDRS); Illness severity change as measured by Clinical Global Impression of Severity for depression(CGI-S-DEP); Change in subject functioning using the Personal and Social Performance Scale.

Conditions

Interventions

PROCEDURE

repetitive Transcranial Magnetic Stimulation (rTMS)

1 Hz; 360 impulsions; on period : 1 min; off period : 30 s.5 sessions per week for 4-6 weeks

BEHAVIORAL

counseling

Placebo monthly by general counseling for 12 months.

Sponsors & Collaborators

  • The No.3 hospital of PLA

    collaborator UNKNOWN

  • The No.91 hospital of PLA

    collaborator UNKNOWN

  • No. 102 Hospital of Chinese People's Liberation Army

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2016-12-30
Completion
2017-02-25

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516931 on ClinicalTrials.gov